NCT04192435View on ClinicalTrials.gov

Tranexamic Acid to Reduce Infection After Gastrointestinal Surgery

PHASE4RecruitingINTERVENTIONAL
Enrollment

3,300

Participants

Timeline

Start Date

May 18, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions
Infection WoundGastrointestinal ComplicationAnesthesiaBleedingHealthcare Associated Infection
Interventions
DRUG

Tranexamic Acid

100mg/ml

DRUG

Placebos

Placebo will be 5ml vials calculated to equivalent to the 100mg/ml of active drug.

Trial Locations (1)

3004

RECRUITING

Alfred Hospital, Melbourne

Sponsors

Lead Sponsor

Bayside Health
All Listed Sponsors
collaborator

National Health and Medical Research Council, Australia

OTHER

lead

Bayside Health

OTHER_GOV